Next Generation Sequencing Market Report 2024-2034

Next Generation Sequencing Market Report 2024-2034

The Next Generation Sequencing Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Research and Clinical Collaborations are Expected to Enhance the NGS Market

Research and clinical collaborations are likely to play a significant role in augmenting the next generation sequencing (NGS) market. These collaborations can drive innovation, reduce costs, and expand the application of NGS technologies. Collaborations bring together experts from various fields, such as genomics, bioinformatics, clinical medicine, and data science, fostering interdisciplinary innovation. A rising number of NGS industry players are developing partnerships with major diagnostics and pharmaceutical businesses, which is a key step towards furthering the use of NGS in clinical settings and personalised medicine. For instance, on 5th January 2024, Illumina Inc., a global pioneer in DNA sequencing and array-based technologies, said that it has entered into a collaboration with Janssen Research & Development, LLC. This will be the first cooperation to create Illumina, Inc. revolutionary molecular residual disease assay, a WGS (whole-genome sequencing) multi-cancer research service that can detect circulating tumour DNA (ctDNA) to better understand disease persistence or recurrence following clinical intervention.

Pricing Pressure has Emerged as a Significant Barrier to the Growth of the Next-Generation Sequencing Market.

Pricing pressure is a significant restraint on the global expansion of the next generation sequencing (NGS) sector. Intense rivalry among prominent NGS providers has caused price wars, which can pressure corporate margins. Emerging companies and alternative sequencing technologies (e.g., nanopore sequencing) further increase competition, forcing existing players to lower prices to remain competitive. Since biopharmaceutical companies are cautious to invest in the discovery of novel drugs, the global clinical research market is currently seeing slow growth. Price pressure is increasing the use of generic medications, which is likely to slow R&D investment growth. Due to easy access to prescriptions, the usage of generic drugs is rapidly increasing over the world. This is projected to have a negative impact on clinical research industry expansion, affecting the NGS market.

What Questions Should You Ask before Buying a Market Research Report?

• How is the next generation sequencing market evolving?
• What is driving and restraining the next generation sequencing market?
• How will each next generation sequencing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
• How will the market shares for each next generation sequencing submarket develop from 2024 to 2034?
• What will be the main driver for the overall market from 2024 to 2034?
• Will leading next generation sequencing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
• Who are the leading players and what are their prospects over the forecast period?
• What are the next generation sequencing projects for these leading companies?
• How will the industry evolve during the period between 2024 and 2034? What are the implications of next generation sequencing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the next generation sequencing manufacturing market?
• Where is the next generation sequencing market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the next generation sequencing market today, and over the next 10 years:

• Our 301-page report provides 118 tables and 185 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them ‚Äì NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising vaccine contract manufacturing prices and recent developments.

Segments Covered in the Report

Type

• Consumables
• Bioinformatics
• Sequencing Services
  
  - Whole Exome Sequencing
  
  
  - Targeted Panels
  
  
  - Whole-genome Sequencing
  
  
  - Others


• Pre-sequencing Services
  
  - Library Preparation and Target Enrichment
  
  
  - Quality Control


• Instruments

Workflow

• Library Preparation
  
  - Semi-automated
  
  
  - Automated


• Sequencing
• Data Analysis
  
  - NGS Primary Data Analysis
  
  
  - NGS Secondary Data Analysis
  
  
  - NGS Tertiary Data Analysis

Application

• Oncology
  
  - Diagnostics and Screening
  
  
  - Research Studies


• Reproductive Health
  
  - NIPT (Noninvasive Prenatal Testing)
  
  
  - PGT (Preimplantation Genetic Testing)
  
  
  - Newborn Genetic Screening
  
  
  - Single Gene Analysis


• Genetic and Rare Diseases
• Consumer Genomics
• Agrigenomics & Forensics
• Others

End-use

• Hospitals and Clinics
• Academic and Research Institutes
• Pharmaceutical and Biotech Companies
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Denmark
• Norway
• Sweden
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Thailand
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA

• GCC
• South Africa
• Turkey
• Rest of MEA

The report also includes profiles for some of the leading companies in the Next Generation Sequencing Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• Illumina, Inc.
• F. Hoffman-La Roche Ltd.
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Eurofins Scientific
• Agilent Technologies
• Tecan Group
• Takara Bio
• 10x Genomics
• GenScript
• Integrated DNA Technologies
• Oxford Nanopore Technologies

Overall world revenue for Next Generation Sequencing Market, 2024 to 2034 in terms of value the market will surpass US$8.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034.Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Next Generation Sequencing Market, 2024 to 2034 report help you?

In summary, our 300+ page report provides you with the following knowledge:

• Revenue forecasts to 2034 for Next Generation Sequencing Market 2024 to 2034, with forecasts for type, workflow, application, and end-use, each forecast at a global and regional level ‚Äì discover the industry‚Äôs prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2034 for five regional and 20 key national markets ‚Äì See forecasts for the Next Generation Sequencing Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Colombia, Germany, France, UK, Italy, Spain, Denmark, Norway, Sweden, China, India, Japan, Singapore, South Korea, Thailand, GCC Countries, South Africa, Turkey, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market ‚Äì including company profiles for 14 of the major companies involved in the Next Generation Sequencing Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Next Generation Sequencing Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.